Maria Lucia Lemos Lopes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Lucia Lemos Lopes has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Rafael Coradin
Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre (RS), Brasil
8 shared publications Bruno Trevisan
Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre (RS), Brazil
7 shared publicationsGabriela Sasso Padilha
Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre (RS), Brazil
7 shared publicationsGilberto Scanagatta
Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre (RS), Brazil
7 shared publicationsLuana Ribeiro Carlos
Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre (RS), Brazil
7 shared publications- Maria Odete Esteves Hilario
Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre (RS), Brasil
7 shared publications
Latest Publications
- Open Access
- 11 February 2025
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 1-16
Recommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren’s disease by the Brazilian Society of Rheumatology
Background: Neurological and psychiatric manifestations occur in patients with primary Sjogren’s disease (SjD) with a wide-ranging clinical presentation, affecting quality of life, social participation, and prognosis. Despite this, neither central nor peripheral neurological symptoms are systematically evaluated in the context of autoimmunity or identified as manifestations of SjD. The EULAR Sjogren’s Syndrome Disease Activity Index (ESSDAI) covers only part of them in the neurological domain. Methods: We performed a systematic review of the diagnosis and prevalence of central, peripheral, and autonomic nervous system manifestations in primary SjD, following the recommendations proposed by the Cochrane Collaboration Handbook. Observational studies were included when their main issue was the diagnosis and the prevalence of the manifestations individually. We employed a generalized linear mixed model (GLMM) method with a random-effects model, and the results were computed using logit transformation, implemented through the ‘meta’ and ‘metafor’ packages in the R software (version 3.6.1). To present these recommendations, agreement among experts was investigated using the Delphi method in in-person meetings. Results: We propose ten recommendations regarding the investigation and management of neurological involvement in SjD that had 100% agreement among participants. Conclusion: These recommendations add to the literature on the clinical care of patients with SjD.
- 11 February 2025
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 1-16
Open AccessRecommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren’s disease by the Brazilian Society of Rheumatology
Background: Neurological and psychiatric manifestations occur in patients with primary Sjogren’s disease (SjD) with a wide-ranging clinical presentation, affecting quality of life, social participation, and prognosis. Despite this, neither central nor peripheral neurological symptoms are systematically evaluated in the context of autoimmunity or identified as manifestations of SjD. The EULAR Sjogren’s Syndrome Disease Activity Index (ESSDAI) covers only part of them in the neurological domain. Methods: We performed a systematic review of the diagnosis and prevalence of central, peripheral, and autonomic nervous system manifestations in primary SjD, following the recommendations proposed by the Cochrane Collaboration Handbook. Observational studies were included when their main issue was the diagnosis and the prevalence of the manifestations individually. We employed a generalized linear mixed model (GLMM) method with a random-effects model, and the results were computed using logit transformation, implemented through the ‘meta’ and ‘metafor’ packages in the R software (version 3.6.1). To present these recommendations, agreement among experts was investigated using the Delphi method in in-person meetings. Results: We propose ten recommendations regarding the investigation and management of neurological involvement in SjD that had 100% agreement among participants. Conclusion: These recommendations add to the literature on the clinical care of patients with SjD.
- Open Access
- 9 July 2024
- Published by Springer Nature in Advances in Rheumatology
- Vol. 64 (1) , 1-11
Recommendations on cutaneous and hematological manifestations of Sjögren’s disease by the Brazilian Society of Rheumatology
Sjogren’s disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and not yet fully understood extraglandular manifestations. To gain a clearer understanding of these manifestations as well as a better practical approach, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of the extraglandular manifestations present in ESSDAI (EULAR Sjogren´s syndrome disease activity index), followed by a voting panel with recommendations for clinical practice. This publication is complementary to others already published and covers cutaneous and hematological manifestations, with prevalence data generated by a meta-analysis of 13 clinical or laboratory manifestations and 6 clinical management recommendations.
- 9 July 2024
- Published by Springer Nature in Advances in Rheumatology
- Vol. 64 (1) , 1-11
Open AccessRecommendations on cutaneous and hematological manifestations of Sjögren’s disease by the Brazilian Society of Rheumatology
Sjogren’s disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and not yet fully understood extraglandular manifestations. To gain a clearer understanding of these manifestations as well as a better practical approach, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of the extraglandular manifestations present in ESSDAI (EULAR Sjogren´s syndrome disease activity index), followed by a voting panel with recommendations for clinical practice. This publication is complementary to others already published and covers cutaneous and hematological manifestations, with prevalence data generated by a meta-analysis of 13 clinical or laboratory manifestations and 6 clinical management recommendations.
- Open Access
- 3 June 2024
- Published by Springer Nature in Advances in Rheumatology
- Vol. 64 (1) , 1-7
Hypocitraturia as a biomarker of renal tubular acidosis in patients with Sjögren’s disease
Introduction: Sjögren’s disease (SD) is an immune-mediated chronic inflammatory disease that affects epithelial tissues, mainly salivary and lacrimal glands. It also presents extraglandular manifestations. The main renal manifestation is tubulointerstitial nephritis (TIN), which can manifest as renal tubular acidosis (RTA). Urinary citrate may be a biomarker of RTA in these patients. The objective of this study was to evaluate whether hypocitraturia is a predictive biomarker of RTA in a sample of patients with SD in a tertiary hospital in southern Brazil. Methods: All patients with SD who met the inclusion criteria and who participated in the rheumatology outpatient clinic of the Irmandade Santa Casa de Misericórdia de Porto Alegre were included. Demographic, SD, serological and urinary data were obtained. RTA was considered in those patients who persistently presented urinary pH above 5.5 and serum pH below 7.35. Patients who persistently had urinary pH above 5.5 underwent a urinary acidification test with furosemide and fludrocortisone. These patients received 1 mg of fludrocortisone and 40 mg of furosemide and had their urine samples tested 2, 4 and 6 h after taking the medications. The test was stopped at any urine sample with pH 5.5 or less. The variables were expressed as mean and standard deviation or interquartile range. The association between hypocitraturia and RTA was assessed using the chi-square. Results: Forty-two patients were included, 95.2% female with a median age of 61.73 years. The prevalence of complete distal RTA was 4.88%. Twenty-eight patients underwent urine acidification testing. Five patients had hypocitraturia, and two of them had complete distal RTA. The association between hypocitraturia and RTA was statistically significant (p < 0.012), with a sensitivity of 100%, specificity of 91.2% and accuracy of 91.7%. The negative predictive value was 100%. The global renal assessment of the population demonstrated two patients with RTA, one patient with decreased renal function and six patients with proteinuria greater than 0.5 g/24 h. Conclusion: The prevalence of RTA in the studied population was 4.88%. Hypocitraturia had high sensitivity and accuracy for the diagnosis of RTA.
- 3 June 2024
- Published by Springer Nature in Advances in Rheumatology
- Vol. 64 (1) , 1-7
Open AccessHypocitraturia as a biomarker of renal tubular acidosis in patients with Sjögren’s disease
Introduction: Sjögren’s disease (SD) is an immune-mediated chronic inflammatory disease that affects epithelial tissues, mainly salivary and lacrimal glands. It also presents extraglandular manifestations. The main renal manifestation is tubulointerstitial nephritis (TIN), which can manifest as renal tubular acidosis (RTA). Urinary citrate may be a biomarker of RTA in these patients. The objective of this study was to evaluate whether hypocitraturia is a predictive biomarker of RTA in a sample of patients with SD in a tertiary hospital in southern Brazil. Methods: All patients with SD who met the inclusion criteria and who participated in the rheumatology outpatient clinic of the Irmandade Santa Casa de Misericórdia de Porto Alegre were included. Demographic, SD, serological and urinary data were obtained. RTA was considered in those patients who persistently presented urinary pH above 5.5 and serum pH below 7.35. Patients who persistently had urinary pH above 5.5 underwent a urinary acidification test with furosemide and fludrocortisone. These patients received 1 mg of fludrocortisone and 40 mg of furosemide and had their urine samples tested 2, 4 and 6 h after taking the medications. The test was stopped at any urine sample with pH 5.5 or less. The variables were expressed as mean and standard deviation or interquartile range. The association between hypocitraturia and RTA was assessed using the chi-square. Results: Forty-two patients were included, 95.2% female with a median age of 61.73 years. The prevalence of complete distal RTA was 4.88%. Twenty-eight patients underwent urine acidification testing. Five patients had hypocitraturia, and two of them had complete distal RTA. The association between hypocitraturia and RTA was statistically significant (p < 0.012), with a sensitivity of 100%, specificity of 91.2% and accuracy of 91.7%. The negative predictive value was 100%. The global renal assessment of the population demonstrated two patients with RTA, one patient with decreased renal function and six patients with proteinuria greater than 0.5 g/24 h. Conclusion: The prevalence of RTA in the studied population was 4.88%. Hypocitraturia had high sensitivity and accuracy for the diagnosis of RTA.
- Open Access
- 10 October 2022
- Published by Springer Nature in Advances in Rheumatology
- Vol. 62 (1) , 1-17
Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic)
Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, some systemic manifestations, mainly liver, gastrointestinal, and pancreatic are not routinely evaluated. To address these manifestations, the Sjögren's Syndrome Committee of the Brazilian Society of Rheumatology conducted a broad systematic review of the literature on studies investigating prevalence and diagnosis of these symptoms in Sjogren´s patients and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. This is the second part of this guideline, providing 6 recommendations for liver, gastrointestinal, and pancreatic care of SS patients.
- 10 October 2022
- Published by Springer Nature in Advances in Rheumatology
- Vol. 62 (1) , 1-17
Open AccessRecommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic)
Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, some systemic manifestations, mainly liver, gastrointestinal, and pancreatic are not routinely evaluated. To address these manifestations, the Sjögren's Syndrome Committee of the Brazilian Society of Rheumatology conducted a broad systematic review of the literature on studies investigating prevalence and diagnosis of these symptoms in Sjogren´s patients and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. This is the second part of this guideline, providing 6 recommendations for liver, gastrointestinal, and pancreatic care of SS patients.
- Open Access
- 1 June 2022
- Published by Springer Nature in Advances in Rheumatology
- Vol. 62 (1) , 1-22
Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal)
Sjogren's Syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, these systemic manifestations are not routinely evaluated and there is no homogenous approach to their diagnosis or evaluation. To close this gap, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of these manifestations and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. The first part of this guideline summarizes the most important topics, and 11 recommendations are provided for the articular, pulmonary, and renal care of SS patients.
- 1 June 2022
- Published by Springer Nature in Advances in Rheumatology
- Vol. 62 (1) , 1-22
Open AccessRecommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal)
Sjogren's Syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, these systemic manifestations are not routinely evaluated and there is no homogenous approach to their diagnosis or evaluation. To close this gap, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of these manifestations and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. The first part of this guideline summarizes the most important topics, and 11 recommendations are provided for the articular, pulmonary, and renal care of SS patients.
- Open Access
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
A TESTICULAR MASS AS THE SOLE MANIFESTATION OF IgG4-RELATED DISEASE
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
Open AccessA TESTICULAR MASS AS THE SOLE MANIFESTATION OF IgG4-RELATED DISEASE
- Open Access
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
DISH AS A CAUSE OF DYSPHAGIA
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
Open AccessDISH AS A CAUSE OF DYSPHAGIA
- Open Access
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
TUBULOINTERSTITIAL NEPHRITIS ASSOCIATED WITH IGG4-RELATED DISEASE IN A FEMALE PATIENT WHIT SYSTEMIC LUPUS ERYTHEMATHOSUS
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
Open AccessTUBULOINTERSTITIAL NEPHRITIS ASSOCIATED WITH IGG4-RELATED DISEASE IN A FEMALE PATIENT WHIT SYSTEMIC LUPUS ERYTHEMATHOSUS
- Open Access
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
IGA NEPHROPATHY IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
Open AccessIGA NEPHROPATHY IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- Open Access
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
ISOLATED POLYOSTOTIC FIBROUS DYSPLASIA: A DIFFERENTIAL DIAGNOSIS IN A TEENAGE PATIENT
- 1 January 2021
- Published by Sociedade Brasileira de Reumatologia
Open AccessISOLATED POLYOSTOTIC FIBROUS DYSPLASIA: A DIFFERENTIAL DIAGNOSIS IN A TEENAGE PATIENT